Intestinal Immunomodulatory Cells (T Lymphocytes): A Bridge between Gut Microbiota and Diabetes.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
diabetes mellitus 3 endocrinologydiseases
niacin 1 endocrinologydiseasesdrugs
type 2 diabetes mellitus 1 endocrinologydiseases
Insulin 1 endocrinologydiseasesdrugs
hyperglycemia 1 endocrinologydiseases
hypoglycemia 1 endocrinologydiseases
metabolic syndrome 1 endocrinologydiseases
obesity 1 endocrinologydiseases
type 1 diabetes mellitus 1 endocrinologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Insulin 5040 a glucose metabolism disorder and is caused by a combination of genetic and environmental factors. Insulin deficiency and insulin dysfunction induce disorders of sugar, fat, protein, water, and electrolyte metabolism,
niacin 17004 epithelial cells to produce TGF-β [[43]]. Gpr109A (encoded by Niacr1) is a receptor for butyrate and niacin in the colon. Butyrate is able to induce the differentiation of Treg cells and IL 10-producing T cells
Select Disease Character Offset Disease Term Instance
diabetes mellitus 2322 is believed that changes in the gut microbiota significantly influence the onset and development of diabetes mellitus (DM), and increasing studies have evaluated the mechanisms underlying this interaction. Recent studies
diabetes mellitus 5651 factors that determines the improvement or deterioration of DM [[13]]. Studies have found that type 2 diabetes mellitus (T2DM) is closely related to human nutritional metabolism, which is also substantially influenced by
diabetes mellitus 7245 the regulation of the gut microbiota may be beneficial for improving diabetes.In patients with type 1 diabetes mellitus (T1DM), the composition of the gut microbiota exhibits substantial changes; its alpha diversity is decreased
hyperglycemia 5196 disorders of sugar, fat, protein, water, and electrolyte metabolism, alone or in combination, and chronic hyperglycemia is the main clinical feature [[12]]. As a multifactorial disease, diabetes requires multivariate treatments
hypoglycemia 6152 methods for the prevention of diabetes.In early studies of nonobese diabetic (NOD) mice with congenital hypoglycemia , diabetes did not develop in normal conditions, but when mice were kept in sterile environments, they
metabolic syndrome 2048 Studies of correlations between the gut microbiota and various diseases, such as diabetes, obesity, metabolic syndrome , liver disease, tumors, and functional constipation, have become increasingly popular, and diabetes
obesity 2039 the body. Studies of correlations between the gut microbiota and various diseases, such as diabetes, obesity , metabolic syndrome, liver disease, tumors, and functional constipation, have become increasingly popular,
type 1 diabetes mellitus 7238 that the regulation of the gut microbiota may be beneficial for improving diabetes.In patients with type 1 diabetes mellitus (T1DM), the composition of the gut microbiota exhibits substantial changes; its alpha diversity is decreased
type 2 diabetes mellitus 5644 environmental factors that determines the improvement or deterioration of DM [[13]]. Studies have found that type 2 diabetes mellitus (T2DM) is closely related to human nutritional metabolism, which is also substantially influenced by

You must be authorized to submit a review.